Endovascular treatment of malignant superior vena cava syndrome: Results and predictive factors of clinical efficacy

CardioVascular and Interventional Radiology

Volumn 36, Issue 1, 2013, Pages 140-149

  Fagedet, Dorothée ^a   Thony, Frederic ^a   Timsit, Jean François ^a,b   Rodiere, Mathieu ^a   Monnin Bares, Valérie ^c   Ferretti, Gilbert R ^a,b   Vesin, Aurélien ^b   Moro Sibilot, Denis ^a,b  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b INSTITUT ALBERT BONNIOT   (France)

^c HÔPITAL ARNAUD DE VILLENEUVE   (France)

Author keywords

Endovascular procedure; Stents; Superior vena cava obstruction; Thoracic neoplasms

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; HEPARIN;

ADULT; ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; BARE METAL STENT; CAVA VEIN OBSTRUCTION; CHRONIC DRUG ADMINISTRATION; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENDOVASCULAR SURGERY; ENDOVASCULAR TREATMENT; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; GUIDE WIRE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MALIGNANT SUPERIOR CAVA VEIN SYNDROME; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; PREDICTION; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; RELAPSE; RETREATMENT; RETROSPECTIVE STUDY; SUPERIOR CAVA VEIN SYNDROME; SUPERIOR CAVA VENA THROMBOSIS; THROMBOSIS; TREATMENT FAILURE; VEIN THROMBOSIS;

AGED; COHORT STUDIES; DISEASE-FREE SURVIVAL; ENDOVASCULAR PROCEDURES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; RECURRENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; STENTS; SUPERIOR VENA CAVA SYNDROME; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84872680170     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0310-z     Document Type: Article

References (25)

1. Wilson LD, Detterbeck FC, Yahalom J (2007) Clinical practice: superior vena cava syndrome with malignant causes. N Engl J Med 356:1862-1869
2. Watkinson AF, Yeow TN, Fraser C (2008) Endovascular stenting to treat obstruction of the superior vena cava. Bmj 336(7658):1434-1437
3. Ostler PJ, Clarke DP, Watkinson AF et al (1997) Superior vena cava obstruction: a modern management strategy. Clin Oncol (R Coll Radiol) 9:83-89
4. Kee ST, Kinoshita L, Razavi MK et al (1998) Superior vena cava syndrome: treatment with catheter-directed thrombolysis and endovascular stent placement. Radiology 206:187-193
5. Uberoi R (2006) Quality assurance guidelines for superior vena cava stenting in malignant disease. Cardiovasc Intervent Radiol 29:319-322
6. Rowell NP, Gleeson FV (2002) Steroids, radiotherapy, chemotherapy and stents for superior vena caval obstruction in carcinoma of the bronchus: a systematic review. Clin Oncol (R Coll Radiol) 14:338-351
7. Urruticoechea A, Mesia R, Dominguez J et al (2004) Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 52 patients with lung cancer. Lung Cancer 43:209-214
8. Lanciego C, Pangua C, Chacon JI et al (2009) Endovascular stenting as the first step in the overall management of malignant superior vena cava syndrome. AJR Am J Roentgenol 193:549-558
9. Berna P, Bagan P, Renard C et al (2008) Pulmonary malignant superior vena cava obstruction: endovascular stent therapy. Rev Pneumol Clin 64:129-132
10. de Gregorio Ariza MA, Gamboa P, Gimeno MJ et al (2003) Percutaneous treatment of superior vena cava syndrome using metallic stents. Eur Radiol 13:853-862
11. Dinkel HP, Mettke B, Schmid F et al (2003) Endovascular treatment of malignant superior vena cava syndrome: is bilateral wallstent placement superior to unilateral placement? J Endovasc Ther 10:788-797
12. Shah R, Sabanathan S, Lowe RA et al (1996) Stenting in malignant obstruction of superior vena cava. J Thorac Cardiovasc Surg 112:335-340
13. Lanciego C, Chacon JL, Julian A et al (2001) Stenting as first option for endovascular treatment of malignant superior vena cava syndrome. Am J Roentgenol 177:585-593
14. Marcy PY, Ianessi A, Poudenx M (2009) Percutaneous management of SVC syndrome: update. J Radiol 90(3 pt 1):335-338
15. Nagata T, Makutani S, Uchida H et al (2007) Follow-up results of 71 patients undergoing metallic stent placement for the treatment of a malignant obstruction of the superior vena cava. Cardiovasc Intervent Radiol 30:959-967
16. Kishi K, Sonomura T, Mitsuzane K et al (1993) Self-expandable metallic stent therapy for superior vena cava syndrome: clinical observations. Radiology 189:531-535
17. Smayra T, Otal P, Chabbert V et al (2001) Long-term results of endovascular stent placement in the superior caval venous system. Cardiovasc Intervent Radiol 24:388-394
18. Nguyen NP, Borok TL, Welsh J et al (2009) Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome. Thorax 64:174-178
19. Ganeshan A, Hon LQ, Warakaulle DR et al (2009) Superior vena caval stenting for SVC obstruction: current status. Eur J Radiol 71:343-349
20. Furui S, Sawada S, Kuramoto K et al (1995) Gianturco stent placement in malignant caval obstruction: analysis of factors for predicting the outcome. Radiology 195:147-152
21. Tanigawa N, Sawada S, Mishima K et al (1998) Clinical outcome of stenting in superior vena cava syndrome associated with malignant tumours. Comparison with conventional treatment. Acta Radiol 39:669-674
22. Thony F, Moro D, Witmeyer P et al (1999) Endovascular treatment of superior vena cava obstruction in patients with malignancies. Eur Radiol 9:965-971
23. Wilson E, Lyn E, Lynn A et al (2002) Radiological stenting provides effective palliation in malignant central venous obstruction. Clin Oncol (R Coll Radiol) 14:228-232
24. Oudkerk M, Heystraten FM, Stoter G (1993) Stenting in malignant vena caval obstruction. Cancer 71:142-146
25. Gross CM, Kramer J, Waigand J et al (1997) Stent implantation in patients with superior vena cava syndrome. AJR Am J Roentgenol 169:429-432